Specialty Pharmacy

Indication for the treatment of adults and pediatric patients with solid tumors containing MSI-H or dMMR.

No evidence found that erectile dysfunction drugs cause melanoma.

Study provides picture of host cell pathway mobilization to HCV.

Top news of the day from across the health care landscape.

Sarilumab plus DMARDs demonstrated statistically significant improvements in patients with moderate to severe RA.

Continuing ART post-delivery shows benefits in women with early stage HIV,

Traps help entomologists track mosquitoes that are carrying Zika or other harmful diseases.

Satisfaction surveys improve understanding of the patient journey and define specialty pharmacy excellence.

Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses how specialty stakeholders can improve clinical and financial alignment.

Top news of the day from across the health care landscape.

Side effects associated with interferon beta for multiple sclerosis highlight the need for additional post-market surveillance for approved drugs.

Imatinib found to reduce measures of airway inflammation in severe asthma.

Top news of the week in oncology and cancer drug development.

Virus-driven immune activation blocks connections between nerve cells in the brain.

A novel AI image detection method could potentially outperform current PAP and HPV tests.

Top articles of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

The Guide to Hepatitis C Testing addresses widespread uncertainty regarding HCV treatment.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Keytruda demonstrated statistically significant improvements in overall survival.

The criminalization of drug use could be detrimental to HIV patient health and does not decrease use, study suggests.

Southern Italy tomato varieties demonstrated a potential role against typical neoplastic features.

Top news of the day from across the health care landscape.

Jonathan Van Lare, PharmD, director of Pharmacy Advantage, discusses the growth of biosimilars in specialty pharmacy.

The approval triples the number of rare gene mutations that ivacaftor can now treat.

Patients with HIV have nearly twice the risk of ischemic heart disease, heart failure, and myocardial infection.

CMS seeks to aid states in creation of high-risk pools and state-operated reinsurance programs.

Pharma manufacturers in the future will reimburse payers on payments for ineffective therapies based on outcomes.